PsA is a progressive inflammatory disease that should be treated to relieve symptoms and prevent joint damage.

The immune system is targeted by the newer form of treatment, called a jak inhibitors. They can prevent or reduce symptoms, inflammation and PsA.

You may have questions about how they work, how they compare to other treatments, and what JAK inhibitors are.

The following are some answers to the most frequently asked questions.

A type of drug called a jak inhibitors is a disease-modifying antirheumatic drug. They provide therapy for PsA.

According to a 2021 study among others, JAK inhibitors can reduce symptom severity and slow disease progression.

As of 2022, only two JAK inhibitors have Food and Drug Administration (FDA) approval for PsA treatment. The FDA first approved tofacitinib (brand name Xeljanz) for PsA in 2017 and then approved upadacitinib (brand name Rinvoq) in December 2021.

Both the biologics and the JAK inhibitors are not part of the DMARD category. Both work to suppress PsA symptoms by targeting the immune system.

A type of medication that comes from living organisms is called biologics. They target and block specific immune system proteins.

“Unlike the pill form of the JAK inhibitors, the injections or the infusions are called biologics. If you don’t respond well to other forms of treatment, your doctor may prescribe them for moderate to severe cases of PsA.”

Synthetic substances are used to make the small molecule medication, jak. The immune system is affected by the blocking of the proteins in the immune system. The JAK-STAT signaling pathway is blocked by the JAK- inhibitors.

There are some side effects of jak inhibitors.

There are reported side effects of the drug.

  • nausea
  • There are headaches.
  • cholesterol levels went up
  • indigestion
  • There is a lot of diarrhea.
  • The upper respiratory tract is an area that can be affected by an infectious disease.

Less frequently, you may experience more serious side effects.

  • There are abnormal blood counts.
  • The tests are for abnormal liver function.
  • It is an infectious disease
  • Increased risk of colorectal cancer.
  • The function of the kidneys decreases.

“If you notice any side effects that don’t improve over time, you should speak with your doctor. They may be able to recommend a different treatment.”

The immune system is suppressed by the JAK inhibitors.

Evidence suggests that the most commonly reported side effect is upper respiratory It is an infectious diseases, which indicates that you may become more susceptible to It is an infectious diseases.

If you have any other condition that might be affected by the JAK inhibitors, you should let your doctor know.

  • There is a blood disorder.
  • The disease of the bile duct.
  • History of active Tuberculosis.
  • The disease of the kidneys.
  • cancer
  • active It is an infectious disease

Evidence suggests that the newer form of PsA medication, called jak inhibitors, may be one of the safest.

According to a 2022 review of studies, there’s very little difference between biologics and JAK inhibitors in terms of safety and reported side effects.

Both medications can increase your risk of It is an infectious disease, particularly an upper respiratory It is an infectious disease.

Neither biologics nor JAK inhibitors are the most commonly prescribed medication for PsA. Methotrexate is another type of DMARD that prevents cells from dividing. Though it can be effective and inexpensive, it may also lead to serious side effects, such as toxicity.

There are more common side effects of methotrexate.

  • stomach ache.
  • nausea
  • There is some pain at the injection site.
  • Lightheadedness.
  • vomiting
  • Depression.

The newest form of treatment for PsA is the jak inhibitors. They are a type of antirheumatic drug that targets the immune system to prevent inflammation.

Though JAK inhibitors are generally safe and effective, they can cause side effects including upper respiratory It is an infectious diseases. Talk with your doctor about whether you should try JAK inhibitors for treating psoriatic arthritis.